The Patent Finder
PL

Plexium, Inc.

First filing 2018
OverviewNotableFeesChangesFamiliesPatent listSources & methods

17 patents currently held

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Sep 2038. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Sep 2038
Next term end
7
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due May 7, 2027
    The maintenance fee for Quinazolinone Compounds and Related Compounds (US 11,807,620) comes due May 7, 2027. Unpaid by Nov 8, 2027, it lapses early.
  • 1 fee due Jul 23, 2027
    The maintenance fee for Aryl Compounds and Pharmaceutical Compositions That Modulate IKZF2 (US 11,878,968) comes due Jul 23, 2027. Unpaid by Jan 24, 2028, it lapses early.
  • 1 fee due Aug 27, 2027
    The maintenance fee for Caps for Assay Devices (US 11,911,760) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

The 5 largest of its 7 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 10,828,643Oligonucleotide Encoded Chemical Libraries
In force
 · Medium confidence
In forceMedium confidence
US 10,946,383Oligonucleotide Encoded Chemical Libraries
In force
 · High confidence
In forceHigh confidence
US 10,981,170Oligonucleotide Encoded Chemical Libraries
In force
 · High confidence
In forceHigh confidence
US 12,030,057Oligonucleotide Encoded Chemical Libraries
In force
 · Medium confidence
In forceMedium confidence
US 11,577,249Oligonucleotide Encoded Chemical Libraries
In force
 · High confidence
In forceHigh confidence
US 12,629,683Oligonucleotide Encoded Chemical Libraries
In force
 · Medium confidence
In forceMedium confidence
US 11,084,037Oligonucleotide Encoded Chemical Libraries
In force
 · High confidence
In forceHigh confidence
US 11,027,272Transfer Dispensers for Assay Devices
In force
 · High confidence
In forceHigh confidence
US 11,040,343Caps for Assay Devices
In force
 · High confidence
In forceHigh confidence
US 11,305,288Assay Devices for Combinatorial Libraries
In force
 · High confidence
In forceHigh confidence
10 of 17 patents shown.
Pro members see all 17.
Pro members: see all 17 patents
Also on record, not counted in the 17: 13 applications pending · 2 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited